U.S. bars federal funding of gender transitions for low-income minors

The U.S. government has finalized a rule barring Medicaid and CHIP from funding gender-affirming care for minors, citing concerns over long-term health risks. The policy, effective in October, shifts the financial burden for these treatments to states and private insurance.
The U.S. government finalised a rule on Tuesday (August 11, 2026) barring two major federal health programmes from funding puberty blockers, hormone therapy and surgeries to treat gender dysphoria in minors, reshaping access for low-income youth nationwide.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in